Navigation Links
Medivation Announces Presentation of Full Top-Line Data From,Dimebon Six-Month Trial at Major International Alzheimer's Disease,Conference

ut Medivation

Medivation, Inc. is a biopharmaceutical company that acquires promising technologies in the late preclinical development phase and develops them quickly and cost-effectively. Medivation's current portfolio consists of small molecule drugs in development to treat three large, unmet medical needs -- Alzheimer's disease, Huntington's disease and hormone-refractory prostate cancer. The Company intends to build and maintain a portfolio of four to six development programs at all times. For more information, please go to http://www.medivation.com.

This press release contains forward-looking statements, including statements regarding the anticipated timing of clinical and regulatory milestones, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve risks and uncertainties that could cause actual results to differ significantly from those projected. You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. You are also cautioned that none of the Company's product candidates has been approved for sale, that significant additional animal and human testing is required in order to seek marketing approval for any of its product candidates, and that Medivation cannot assure you that marketing approval can be obtained for any of its product candidates. Medivation's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-KSB for the year ended December 31, 2006, include more information about factors that could affect the Company's financial and operating results.

CONTACT: Patrick Machado, Chief Financial Officer, Medivation, Inc.,+1-415-543-3470, ext. 201; or Jani Bergan of WeissComm Partners,+1-415-946-1064, for Medivation; or Lori Williams of Baylor College ofMedicine, Office of Public Affairs
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Medivations Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimers Disease Trial After One Year of Therapy
2. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
3. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
4. Medivation Announces First U.S. Presentation of Data From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
(Date:7/30/2014)... 30, 2014 Silicon Valley Bank, the bank ... today that examines the merger, acquisition and IPO ... According to the annual report based on 2013 data, ... since SVB started tracking the data in 2005. ... on solid healthcare M&A activity over the last few ...
(Date:7/30/2014)... LONDON , July 30, 2014  Lightlake ... developing addiction treatments based on its expertise in ... a funding commitment from a prominent international research ... a focus on promoting innovative research-based initiatives, including ... a nasal spray for the delivery of naloxone ...
(Date:7/30/2014)... , July 30, 2014   Epic ... company that designs and develops novel diagnostics to ... cancer, announced today the completion of a $30 ... included new investors RusnanoMedInvest (RMI) and Arcus Ventures, ... Pfizer Venture Investments, as well as undisclosed individual ...
Breaking Medicine Technology:Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 2Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 3Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 2Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 3
... AuraSense Therapeutics, a biopharmaceutical company commercializing spherical ... and chemo-therapeutics for a variety of diseases, ... for cardiovascular disorders, has closed its Series ... a subsidiary of Abbott.  Other key individual ...
... 2011 /PRNewswire-Asia/ -- The Ministry of Health and ... Industry Development Institute (President Ko Kyung-hwa) launched a ... foreign patients by designating 38 tasks, including seven ... for medical injuries and granting permission for drug ...
Cached Medicine Technology:AuraSense Therapeutics Secures Series B Equity Investment 2Medical Korea's Medical Policy Improvement Project for Foreign Patients 2
(Date:7/30/2014)... Children’s Hospital of Michigan Foundation and Kohl’s ... p.m. to 7 p.m. Wednesday, August 6 at the ... MI 48152). The event will feature Detroit Red Wings ... snacks and local public safety officials. Kohl’s will present ... Michigan Foundation. , The gift supports Kohl’s Injury ...
(Date:7/30/2014)... July 30, 2014 2014 ... Chitosan Industry” is a professional and in-depth ... The report provides basic Chitosan information, including ... structure as well as industry overview. This ... domestic market as well as global industry ...
(Date:7/30/2014)... HealthDay Reporter WEDNESDAY, July 30, 2014 ... soothe the agitation that commonly strikes people with dementia, a ... researchers found evidence that watering plants, or sitting or strolling ... The study authors cautioned that the effects of gardens ... and the evidence of a benefit is limited. But experts ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 According ... and Machine Vision Market by Technology (ICS, MES, ... Embedded), Components (Camera, FGOL), Application (Process, Discrete) - ... published by MarketsandMarkets, the Mexican market is expected ... 6.18% by 2020. , Browse 70 market data ...
(Date:7/30/2014)... July 30, 2014 Shabaikai is an ... forests of the Pomo Indians located on the shores ... the river Shabaikai, meaning ‘crooked snake’. Clarkson takes the ... and the violence of prohibition and organized crime, providing ... River. Here, the most powerful men in the world ...
Breaking Medicine News(10 mins):Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 2Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 3Health News:Kohl’s, Children’s Hospital of Michigan Foundation Host Safety Day with Detroit Red Wings Defenseman Danny DeKeyser, Bike Helmets, Family Activities and More 4Health News:Chitosan Market & Sialic Acid Industry Research Analysis for World, China Regions Available at DeepResearchReports.com 2Health News:Chitosan Market & Sialic Acid Industry Research Analysis for World, China Regions Available at DeepResearchReports.com 3Health News:Chitosan Market & Sialic Acid Industry Research Analysis for World, China Regions Available at DeepResearchReports.com 4Health News:Gardens a Center of Calm for People With Dementia 2Health News:Gardens a Center of Calm for People With Dementia 3Health News:Mexico Factory Automation and Machine Vision Market Worth $6.99 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Mexico Factory Automation and Machine Vision Market Worth $6.99 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Mexico Factory Automation and Machine Vision Market Worth $6.99 Billion by 2020 - New Report by MarketsandMarkets 4Health News:Bill E. Clarkson Releases Debut Fact-Based Novel, Shabaikai 2
... free gig in Ukraine to promote HIV-Aids awareness. The ... was attended by 200,000 people including President Viktor ... of the singer whose Aids foundation already funds projects ... with some appreciating it and others slamming the show. ...
... senior British Army surgeon said troops injured in the ... hours before being transported to field hospitals, newspapers reported ... 40-odd years ago were treated far more quickly than ... Mirror reported Lieutenant Colonel Paul Parker as saying. ...
... in Rajasthan but the number of panthers is slowly on ... of Rajasthan, said early estimates of the census figures indicated ... state. ,According to the 2004 wildlife census, there ... houses the Ranthambore National Park, has the maximum number at ...
... that an enzyme beta-secretase or BACE, involved in the ... can also alter neural activity in the brain , ... study might put light on the high occurrence of ... might block this enzyme could lessen the incidences of ...
... shuttle have completed a fourth space walk on the ... National Aeronautics and Space Administration (NASA) said Monday. ... and Steven Swanson managed to activate a Solar Alpha ... rotate towards the sun. ,They also laid ...
... over exhaustive plans for its survival, some tourists and locals ... - fishing out tonnes of garbage that threatens to ... including foreign and domestic tourists, houseboat owners and voluntary groups ... other litter from the lake Monday. ,The effort ...
Cached Medicine News:Health News:Wounded British Troops Wait Hours to Reach Hospital 2Health News:Alzheimer's-associated Enzyme Linked to Seizures 2Health News:Volunteers Remove Garbage from Kashmir's Dal Lake 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: